Harms
diarrhoea, ARI
ADVERSE EVENTS, GASTROINTESTINAL DISORDERS
Only one clindamycin-treated participant experienced adverse events (gastrointestinal disorders and diarrhoea), thus yielding no significant differences between the groups (RR: not estimable, ARI = 0.03; CI: − 0.05–0.11, NNH = 31; CI: 8.5–∞, and 